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ABSTRACT
Ribosome biogenesis is a key process for maintain-
ing protein synthetic capacity in dividing or growing
cells, and requires coordinated production of ribo-
somal proteins and ribosomal RNA (rRNA), including
the processing of the latter. Signalling through
mammalian target of rapamycin complex 1
(mTORC1) activates all these processes. Here, we
show that, in human cells, impaired rRNA process-
ing, caused by expressing an interfering mutant of
BOP1 or by knocking down components of the
PeBoW complex elicits activation of mTORC1
signalling. This leads to enhanced phosphorylation
of its substrates S6K1 and 4E-BP1, and stimulation
of proteins involved in translation initiation and
elongation. In particular, we observe both inactiva-
tion and downregulation of the eukaryotic elong-
ation factor 2 kinase, which normally inhibits
translation elongation. The latter effect involves
decreased expression of the eEF2K mRNA. The
mRNAs for ribosomal proteins, whose translation
is positively regulated by mTORC1 signalling, also
remain associated with ribosomes. Therefore, our
data demonstrate that disrupting rRNA production
activates mTORC1 signalling to enhance the effi-
ciency of the translational machinery, likely to help
compensate for impaired ribosome production.
INTRODUCTION
Ribosome biogenesis, the production of new ribosomes,
plays key roles in cell growth and division by providing
increased capacity for protein synthesis (1,2). The transcrip-
tion of the major ribosomal RNAs (rRNAs) and their
processing, along with the assembly of new ribosomal
subunits, occur within nuclear regions termed nucleoli (3).
The importance of enhanced ribosome biogenesis for
cell proliferation is exemplified by the early observation
that nucleolar morphology is markedly altered in cancer
cells (4), reflecting their faster rates of ribosome produc-
tion. It is now widely recognized that increased ribosome
biogenesis is of key importance in cancer (4) and other
disorders of cell proliferation or growth [such as cardiac
hypertrophy (5,6)]. Ribosome biogenesis requires the
coordinated synthesis of four rRNAs and >80 ribosomal
proteins (RPs). It consumes large amounts of metabolic
energy, amino acids and ribonucleotides. The mammalian
target of rapamycin complex 1 (mTORC1, a protein
kinase) positively regulates the transcription and process-
ing of rDNA and the translation of the mRNAs for RPs
(2,7).
mTORC1 contains mTOR (the catalytic subunit) and
raptor, a scaffold protein that recruits substrates for phos-
phorylation by mTOR. The best-known mTORC1 sub-
strates are the RPs S6 kinases (S6K1/2) and the
eukaryotic initiation factor 4E (eIF4E)-binding proteins
(4E-BPs) (8).
A number of studies have revealed roles for mTOR
signalling in rRNA synthesis in yeast and in mammalian
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cells [reviewed in (2,9,10)]. The 5.8S, 18S and 28S rRNAs
are made by RNA polymerase I (Pol I), while the 5S
rRNA is made by Pol III. mTORC1 promotes the
activities of Pol I and Pol III, as revealed by the inhibitory
effects of rapamycin, a specific inhibitor of mTORC1 (2).
However, rapamycin does not inhibit all the functions of
mTORC1, as exemplified by the effects of compounds
such as PP242, which directly inhibit mTOR’s kinase
activity (11–13). A second, distinct mTOR complex,
mTORC2, phosphorylates several protein kinases,
including protein kinase B [PKB, also termed Akt (14)].
In turn, PKB, whose activity is stimulated by insulin, con-
tributes to the activation of mTORC1 by phosphorylation
and inactivation of tuberous sclerosis 2 (TSC2), a negative
regulator of mTORC1 [reviewed (15)].
One mechanism by which mTORC1 may promote
rRNA transcription through S6K1-dependent control of
Pol I, which positively regulates rRNA synthesis as shown
by the finding that it can rescue Pol I-mediated transcrip-
tion from inhibition by rapamycin (16), perhaps via the
regulation of the Pol I transcription regulatory component
UBF [upstream binding factor; (17)] by S6K1. However,
the exact mechanisms by which mTORC1 or S6K1 control
Pol I remain to be clarified.
Pol I generates a single rRNA precursor, the 47S pre-
rRNA, which is processed to yield the mature 5.8S, 18S
and 28S rRNAs. Pre-rRNA maturation involves a large
number of components including the PeBoW complex,
comprising the proteins PES1, BOP1 and WDR12 (18).
The importance of this complex for rRNA processing is
illustrated, for example, by the fact that a truncated
version of BOP1 (BOP1) interferes with processing of
the 32S pre-rRNA intermediate into 28S rRNA (19). We
previously showed that rapamycin or the mTOR kinase
inhibitor AZD8055 (20) interferes with pre-RNA process-
ing (7), although the mechanism(s) that link mTORC1 to
this process remain unclear.
mTORC1 signalling also contributes to the activation
of ribosome biogenesis by promoting the translation of the
mRNAs encoding RPs. They contain a 50-terminal tract of
pyrimidines (50-TOP) that confers control by mTORC1 of
the recruitment of ribosomes on to these messages, which
also include mRNAs encoding all translation, elongation
and several initiation factors (21).
In addition to enhancing the protein synthetic capacity
of cells by promoting ribosome production, mTORC1
also promotes the translational efficiency of cells, by
activating translation initiation by alleviating the inhib-
ition of eukaryotic initiation factor eIF4E by 4E-BPs
and translation elongation via the inactivation of eukary-
otic elongation factor 2 kinase [eEF2K; a substrate for
S6K1 (22)] and the resulting dephosphorylation and acti-
vation of eEF2 (23). eEF2K can also be controlled
through additional mechanisms, some of which are
mediated by mTORC1 (23,24).
Given the importance of ribosome biogenesis, both in
normal cell physiology and in disease states, it is import-
ant to gain a much better understanding of its control, e.g.
by mTORC1. Furthermore, it is not clear whether and
how ribosome biogenesis is coupled to the rate of
protein synthesis or vice versa.
Here, we have asked how mammalian cells respond to
impaired production of rRNA. We show that interference
with rRNA processing, and therefore with the production
of mature rRNAs for ribosome biogenesis, leads to acti-
vation of S6K1 and the disinhibition of the initiation and
elongation stages of mRNA translation. Thus, these data
reveal a feedback mechanism in mammalian cells, whereby
defects in rRNA biosynthesis cause the activation of
mTORC1 signalling and of components involved in
rRNA transcription and mRNA translation. In addition
to helping promote ribosome biogenesis in response to
defective rRNA maturation, this mechanism likely acts
to allow cells to maximize the efficiency of the existing
translational machinery under conditions where rRNA
synthesis is impaired.
MATERIALS AND METHODS
Chemicals and antibodies
Doxycycline was purchased from Fisher, MG132 from
Calbiochem, rapamycin from Merck, PP242
from Sigma-Aldrich, AZD6244 from Selleck and
PF4708671 from Tocris. The anti-myc and anti-B23
antibodies were purchased from Sigma-Aldrich; anti-HA
was from Roche Applied Sciences; anti-raptor, rictor,
4E-BP1, PKB and their phosphorylation site-specific
antibodies were from Cell Signalling Technology; anti-
tubulin, anti-RPL11, anti-RPL28 and anti-RPS6 were
from Santa Cruz Biotechnology. Secondary antibodies
were from Li-Cor Biosciences. Anti-LAMP2 was
purchase from Abcam.
Vectors and oligonucleotides
The pEBG-6P empty vector was derived from pEBG2T as
described in (25). pGEX-6P-1 was purchased from
Amersham, pCDNA5FRT and pOG44 were from
Invitrogen. pGEX-6P-4E-BP1 and its mutation were
described previously (26). The cDNA clone for human
BOP1 was purchased from Origene and subcloned into
appropriate vectors for expression as a glutathione
S-transferase (GST) fusion protein in bacteria
(pGEX6p-1, between the EcoR1 and Not1 sites) or mam-
malian cells by transient transfection (pEBG6P-1, between
the Spe1 and Cla1 sites) or in a doxycycline-inducible
manner (pCNDA5FRT, HindIII+XhoI). The truncation
mutant of BOP1 was created by polymerase chain reaction
(PCR) and cloned similarly. All vectors were fully
sequenced after construction or mutagenesis.
siRNA oligonucleotides for BOP1, PES1, WDR12 and
scrambled siRNA were from (27). The siRNAs used were
as follows: BOP1-1, UCGUGCUGAAGUCAACAG
AdTdT; BOP1-2, dCCAAGAAGCUGAUGCCCA
AdTdT; WDR12-2, CGUACGUUUCCGUGGGCA
AdTdT; PES1, CCAGAGGACCUAAGUGUGAdTdT;
scrambled, UUCUCCGAACGUGUCACGUdTdT. The
expression vectors for V5-tagged Rag mutants were
described in (28).
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Immunoprecipitation and S6K1 kinase assay
Ten microlitres of protein G-Sepharose beads and 0.5mg
of anti-HA high-affinity antibody were incubated together
at 4C for 2 h, then unbound antibody was washed away
by lysis buffer. One milligram of crude lysate from trans-
fected cells was added into protein G-Sepharose slurry.
After 1 h of incubation at 4C, the protein G-Sepharose
beads were washed twice with lysis buffer.
Purified HA-S6K1 was immunoprecipitated from dif-
ferent groups of cells. Kinase reactions were performed
by incubating HA-S6K1 with 5 nmol ‘Crosstide’ substrate,
1.25 nmol cold ATP, 0.3 mCi of [g-32P]ATP and kinase
buffer in a final volume of 20 ml. Kinase reactions were
performed at 30C for 15min, transferred samples onto
filters and then placed into 150mM phosphoric acid. The
filters were washed three times with phosphoric acid.
Radioactivity associated with the filters was determined
using a Cˇerenkov programme.
Cell lysis and western blotting
Cells were lysed directly on the plate by the addition of cold
lysis buffer [50 mM Tris–HCl, 50mM b-glycerophosphate,
1mM ethylene glycol tetraacetic acid (EGTA), 1mM
ethylenediaminetetraacetic acid (EDTA) and 1% (v/v)
Triton X-100]. b-Mercaptoethanol, Na3VO4 and protease
inhibitor cocktail were added to the lysis buffer just before
use. Lysates were centrifuged at 4C at maximum speed
for 10min and then the supernatant was collected.
Protein concentrations were determined by Bradford
reagent (Bio-Rad). Cell lysates or immunoprecipitated
samples were heated at 95C for 5min in sample buffer
[62.5mM Tris–HCl, 7% (w/v) sodium dodecyl sulfate
(SDS), 20% (w/v) sucrose and 0.01% (w/v) bromophenol
blue] and subjected to polyacrylamide gel electrophoresis
(PAGE) and electrophoretic transfer to nitrocellulose/
polyvinylidene difluoride membranes. Membranes were
then blocked in phosphate-buffered saline (PBS)-Tween
20 containing 5% (w/v) skimmed milk powder for 30min
at room temperature. Membranes were probed with the
indicated primary antibody overnight at 4C. After incuba-
tion with fluorescently tagged secondary antibody, signals
were scanned using a Li-Cor Odyssey imaging system.
Measurement of protein synthesis rates
T-REx cells were starved in methionine-free medium
(Biosera DMEM SM-D3666) for 1 h and incubated with
[35S]methionine (Perkin Elmer; 10 mCi/ml) for 1 h at 37C.
After this incubation, the medium was removed com-
pletely and the cells were washed in ice-cold PBS and
lysed in 50mM Tris–HCl (pH 7.5), 50mM
b-glycerophosphate, 100mM NaCl, 0.5mM EDTA and
1% Triton X-100. The protein concentrations were then
quantified using the Bradford. Lysate (5ml) was applied to
3MM filter papers (Whatman), which were washed twice
with 5% (w/v) trichloracetic acid and once in acetone
(100%). Incorporated radioactivity was measured by scin-
tillation counting.
eEF2 kinase assay
Recombinant eEF2 (1 mg) was incubated with Ca2+/CaM
(0.2mM/10 mg/ml) and [g-32P]ATP (0.1mM, 1 mCi per
reaction) in 30 ml of reaction buffer containing
[g-32P]ATP [final concentration 0.1mM, 1 mCi per
reaction; 50mM3-(N-morpholino)propanesulfonic acid,
pH 7.0 (unless pH stated otherwise), 20 mg/ml CaM
(where present), 5mMMgCl2, 14mM b-mercaptoethanol,
0.67mM CaCl2, 2mM EDTA, 0.4mM EGTA, 1mM
benzamidine-HCl and 1mM each of leupeptin, pepstatin
and antipain] at 30C for 15min. SDS-PAGE was per-
formed followed by staining with coomassie brilliant
blue, the gels were placed into destain/fixing solution
[50% (v/v) methanol, 10% (v/v) acetic acid].
Radioactivity was detected using phosphor imager
screen (Typhoon, GE Healthcare).
Polysome analysis and northern blot analyses
T-REx cells had been washed twice with ice-cold PBS and
lysed directly on the plate with 300 ml of lysis buffer
(10mM NaCl, 10mM MgCl2, 10mM Tris–HCl, pH 7.5,
1% Triton-X100, 1% sodium deoxycholate, 36 U/ml
RNase inhibitor (Promega) and 1mM dithiothreitol).
Sucrose gradient density centrifugation was performed
as recently described (7). RNA was isolated by proteinase
K method (7) or proteins were precipitated from each
fraction using trichloroacetic acid (TCA) at a final con-
centration of 10% (w/v). Radiolabelled probes were
prepared by random priming as described earlier (7).
Ribosome fractionation
The cells lysed in tetranitromethane buffer were
centrifuged in a Beckman T70.1 rotor for 2 h at
100 000g on a 25% (v/v) sucrose cushion. After centri-
fugation, two fractions were obtained: fraction P (pellet),
which includes polysomes and ribosomal subunits, and
fraction S (supernatant), which includes cytoplasmic
proteins. The proteins from fraction S were precipitated
with 10% TCA and the proteins in fraction P were directly
resuspended in SDS-PAGE loading buffer.
Proliferation assay
T-REx cells (non-induced or induced with 1 mg/ml doxy-
cycline) were split in triplicate in six-well plates in
DMEM medium containing 10% foetal bovine serum.
Every 48 h, cells were counted with a Neubauer counting
chamber. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide(MTT) assay (M2003, Sigma-Aldrich)
was performed as recommended by the manufacturer.
RNA preparation, northern blot and pre-rRNA species
Total RNA was extracted by the proteinase K method (7).
For northern blot analysis, RNA (2mg) was run on 1.5%
agarose-formaldehyde gels and transferred to GeneScreen
Plus membrane (PerkinElmer Life Sciences) for 15 h at
4C. Northern blotting was performed as recommended
by the manufacturer. Oligonucleotides were end-labelled
with [a-32P]ATP and T4 polynucleotide kinase (BioLabs
M0201S) for 30min at 37C. Membranes were hybridized
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overnight in hybridization buffer (6 saline–sodium phos-
phate–EDTA (SSPE), 5 Denhardt‘s solution, 0.1mg/ml
fish sperm DNA and 1% SDS). Washing was performed
in 2 SSPE, 1% SDS at 65C for 30min.
The pre-rRNA species were detected using oligodeoxy-
nucleotide complementary to the human rDNA: 50ITS2
(50-CGCACCCCGAGGAGCCCGGAGGCACCCCCGG-
30). Membranes were exposed to storage phosphor screen
(GE-Healthcare) and analysed using a phosphorimager
(STORM, GE Healthcare). Quantitation of northern blots
was performed using the Image-Quant software (Amersham
Biosciences).
RT-Real time PCR amplification analysis
Total RNA (2mg) was extracted by the proteinase K
method (7) and then subjected to ImProm-IItm Reverse
Transcription System (A3800 Promega) with oligo(dT)15
and random primers following the manufacturer’s
protocol. Subsequently, the real-time PCR was performed
using specific primers (PrimerDesign) for eukaryotic
elongation factor-2 kinase (eEF2K) (50-CCAGCCAAGA
CTTCAGTGTT-30; 50-ATTTTACCTGCTTCATTGTTC
ATTTAA-30), b-actin (50-CATTGGCAATGAGCGGTT
C-30; 50-CCACGTCACACTTCATGATGG-30) and p21
(50-GCAGACCAGCATGACAGATTT-30; 50-AAGATG
TAGAGCGGGCCTTT-30). The samples were analysed
in triplicate with SYBR Green dye (Primer Design mix)
on an ABI StepOnePlus quantitative PCR instrument
(Applied Biosystems). The comparative Ct method was
used to measure amplification of eEF2k mRNAs versus
b-actin.
Amino acid levels
Levels of amino acids in cell lysates were determined as
described (29).
Chromatin cross-linking and immunoprecipitation—ChIP
T-REx cells were induced for 15 h with 1 mg/ml doxycyc-
line. Cross-linking was performed by adding 1% formal-
dehyde for 10min at room temperature. The cells were
lysed in 350 ml of lysis buffer (1% SDS, 10mM EDTA,
50mM Tris–HCl, pH 8.1) and sonicated seven times for
20 s. The ChIP antibody used was specific for UBF (Santa
Cruz, #9131). For normalization, an input of DNA was
prepared and subject to qPCR analysis using primers
specific for rDNA region (50-CGACGACCCATTCGAA
CGTCT-30; 50-CTCTCCGGAATCGAACCCTGA-30).
The samples were analysed with SYBR Green dye
(Primer Design mix) on an ABI StepOnePlus quantitative
PCR instrument (Applied Biosystems).
Immunostaining
Cell imaging was performed with a confocal laser-
scanning microscope (Leica SP5). Chambered coverslips
were used for immunostaining. Cells were fixed with 4%
(v/v) para-formaldehyde for 5min and permeabilized with
PBS 0.1% Triton X100 for 2min. Cells were rinsed three
times with PBS and then incubated with PBS containing
0.5% (w/v) bovine serum albumin (BSA) for 1 h at room
temperature. Primary antibodies, diluted at 1/200 in PBS
containing 0.5% BSA, were incubated at 4C for 16 h.
Secondary antibodies, diluted at 1/500 in PBS containing
0.5% BSA, were incubated at room temperature for 1 h in
the dark.
The Costes’ approach was used to quantify the protein–
protein co-localization in cells using MBF ImageJ. This
allows for the calculation of Pearson’s correlation coeffi-
cient R(obs) between n images. In theory, an R(obs) of+1
would represent a perfect pixel correlation between
two channels in an image, whereas an R(obs) of 0 repre-
sent a random correlation and therefore no co-
localization.
Cells inducibly expressing BOP1"
Cell lines inducibly expressing BOP1 mutant was
generated by using Invitrogen’s FLP/FRT system accord-
ing to the manufacturer’s instructions.
RNA preparation and biotinylation of 4-TU-labelled RNA
The procedure for labelling newly synthesized RNA was
described in (7). The 28S, 18S and p21 primers were
purchased from PrimerDesign.
Subcellular fractionation
T-REx cells were washed twice with ice-cold PBS and re-
suspended in cold buffer A (10mM Tris–HCl, pH 7.5,
10mM NaCl, 3mM MgCl2, 0.05% of Nonidet P-40 and
protease inhibitor). The cell lysates were centrifuged at 100
rcf for 5min at 4C. After removal of the supernatant (the
cytoplasmic fraction), the resulting pellet (the nuclear
fraction) was washed five to six times with buffer A and
resuspended in cold buffer B [20 mM Tris–HCl, pH 7.5,
420mM NaCl, 1.5mM MgCl2, 1mM EDTA, 1mM
EGTA, 20% (v/v) glycerol, 1% (v/v) Triton and
protease inhibitors]. The nuclear extract was incubated
for 1 h at 4C on a rotating tube mixer. It was then
centrifuged for 10min at 15 000 rcf at 4C, after which
the supernatant was carefully collected.
RESULTS
Expression of BOP1" promotes activation of S6K1
The truncation mutant of mouse BOP1 lacking residues
1–250 has been shown to interfere with processing of the
47S rRNA precursor (30). To explore the effects of
interfering with ribosome biogenesis on the signalling
pathways involved in this process and the control of
mRNA translation, we tested the effect of expressing the
equivalent truncation of human BOP1 (lacking residues
1–264) in HEK293 cells. We initially used GST-tagged
BOP1 or BOP1 because this tag allows us to perform
diverse types of experiments. As reported for mouse cells
(30), expressing BOP1 interferes with processing of pre-
rRNA in human cells, as shown by accumulation of 32S
pre-rRNA relative to the 28S (Figure 1A).
To examine the cellular response to interference with
rRNA processing, we monitored the activation state of
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Figure 1. Expressing BOP1 elicits activation of S6K1. (A) Northern blot hybridization of total RNA. HEK293 cells were transiently transfected
with 1 mg of GST-BOP1, GST-BOP1 or GST vectors. After 48 h, total RNA was extracted and subjected to northern blot analysis using a probe
specific for the precursors corresponding to the 50-end of ITS2. The numbers below the lanes refer to the quantification for the 32S normalized to the
signal for 28S (control value set at 1). (B) HEK293 cells were transfected with 0.5 mg of HA-S6K1 DNA and series of concentrations of GST-BOP1
DNA. After 48 h, cells were harvested, and 20 mg of lysate was analysed by western blots using the indicated antisera. (C) HEK293 cells were
transfected with 0.5 mg of HA-S6K1 DNA and 1mg of GST-BOP1, GST-BOP1 or GST DNA as indicated; 35 h later, where indicated, cells were
treated with rapamycin (100 nM) for 45min. HA-S6K1 was immunoprecipitated from 1mg of total lysate. Immunoprecipitates were aliquoted into
three equal portions: two were analysed by western blot to verify the IP efficiency, while the third was used for S6K1 assay. Total lysates were
analysed by western blot to confirm expression of GST-tagged proteins. (D) Expression of BOP1 was induced by treating T-REx cells for 15 h with
1 mg/ml doxycycline. Total RNA was extracted and subjected to northern blot to detect the pre-rRNA (using the ITS2 probes).The numbers below
the lanes refer to the quantification for 32S: 28S as in panel (A). (E) T-REx cells were treated with doxycycline for the indicated times, harvested and
20 mg of lysate was analysed by western blots; p85 and p70 denote the different isoforms of S6K1, which are observed here. (F) T-REx cells were
treated with 1 mg/ml doxycycline for 15 h before addition of 4-SU. Total RNA was extracted after 4 h and processed to measure levels of labelled 28S
rRNA, relative to total 18S rRNA, as described in the ‘Materials and Methods’ section. (G) Cell lysates were subjected to affinity chromatography
on m7GTP–Sepharose and the bound material was analysed by western blot. Numbers show the quantification for eIF4G:eIF4E and 4E-BP1:eIF4E
binding from a typical experiment (untreated cells value set at 1). (H) Cells were treated with doxycycline as in panels E and G. Twenty micrograms
of lysate was analysed by western blot. Significance was determined by t-test.
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the mTORC1 pathway, which promotes both ribosome
biogenesis and mRNA translation (2,23), by studying
the phosphorylation of S6 kinase 1 (S6K1). Expressing
GST-BOP1 caused a dose-dependent increase in phos-
phorylation of S6K1 at Thr389, a key residue for its
activation, which is phosphorylated by mTORC1 (31)
(Figure 1B). At equivalent levels of expression, BOP1
stimulated S6K1 phosphorylation more strongly than
full-length BOP1 (Figure 1C and Supplementary Figure
S1A). Immunoprecipitation of the co-expressed
HA-S6K1, followed by a kinase assay, confirmed that
expression of BOP1, and to a lesser extent, BOP1, did
activate S6K1 (Figure 1C). The activation of S6K1 caused
by expressing by BOP1 was completely blocked by
rapamycin, indicating that, as expected, it is mediated
via mTORC1 in this setting (Figure 1C).
It was possible that BOP1 activated mTORC1 inde-
pendently of the mechanisms that normally control its
activity: mTORC1 signalling normally requires amino
acids and is further activated by, for example, insulin
[see, e.g. (32)]. BOP1 markedly potentiated the phos-
phorylation of S6K1 observed in the presence of amino
acids/insulin (Supplementary Figure S1B). However,
S6K1 phosphorylation was still stimulated by amino
acids, and was further enhanced by insulin, indicating
that BOP1 enhances S6K1 activation without bypassing
the normal control of mTORC1 signalling.
Effects of inducible expression of BOP1"
To obviate the limitations imposed by transient transfec-
tion, we created a stable cell line in which BOP1 can be
expressed in an inducible manner, and replaced the GST
tag with the smaller myc tag. Like endogenous BOP1 (7),
myc-BOP1 was primarily nuclear (Supplementary
Figure S2A). Induction of myc-BOP1 interfered with
rRNA processing, increased the levels of the 32S rRNA
precursor (Figure 1D) and elicited phosphorylation of
S6K1 (Supplementary Figure S2B) in a time-dependent
manner (Figure 1E). Phosphorylation of PKB at Ser473
was unaffected (Figure 1E), indicating that BOP1 does
not alter mTORC2 function. Induction of myc-BOP1
also enhanced the transcription of p21 (Supplementary
Figure S2C), a gene that responds to p53, which is
stabilized in response to ribosomal stress (33).
Induction of myc-BOP1 also impaired cell prolifer-
ation (cell number; Supplementary Figure S2D), accu-
mulation of cell mass (MTT assay, Supplementary
Figure S2E), impairment of UBF binding to the Pol I
promoter (Supplementary Figure S2F). Therefore, the
inducible expression of myc-BOP1 exerts similar
effects to those reported for transient expression of
BOP1 (19,30). In addition, we studied the distribution
of the nucleolar protein B23 (Supplementary Figure
S2G) following knock-down of BOP1. RNA-interfer-
ence-mediated knock-down of BOP1 caused an
increase of localization in the nucleoplasm of B23
similar to the actinomycin D treatment shown previ-
ously (7). These data support the conclusion that
defects in BOP1 cause nucleolar stress.
As S6K1 has been shown to positively regulate rRNA
transcription [reviewed in (9)], this could constitute
a ‘rescue’ mechanism to promote rRNA synthesis in
response to inadequate ribosome production. To
study rRNA synthesis, we used a non-radioactive labelling
method [whereby new rRNA is tagged with 4-thiouracil,
4SU (7)]. The data (Figure 1F) reveal a decrease in the
accumulation of new labelled rRNA in cells expressing
BOP1 perhaps because impairing rRNA processing
destabilizes new rRNA, in an analogous way to the effect
of rapamycin, which also interferes with processing (7).
This is consistent with the observation that expressing
BOP1 markedly impaired the association of UBF with
rDNA (Supplementary Figure S2F). Thus, although
mTORC1 signalling and the S6Ks are implicated in
promoting Pol I transcription (9,17), the activation of
mTORC1 signalling induced by BOP1 is insufficient to
promote accumulation of new rRNA in the face of
impaired pre-rRNA processing. It is not clear whether
the impaired accumulation of new rRNA is only due to
inhibition of transcription, or whether increased decay of
new pre-rRNA may also contribute to this.
Inducible expression of BOP1" causes activation of
translation initiation and elongation factors
The translational repressor protein, 4E-BP1, undergoes
phosphorylation by mTORC1 at multiple sites, retard-
ing its mobility on SDS-PAGE. In cells expressing
BOP1, 4E-BP1 underwent an upward mobility shift
(Figure 1E), indicating its increased phosphorylation
(N.B. all three species of 4E-BP1 observed in this figure
are phosphorylated on T37/46; they differ in their
phosphorylation at other sites). This further supports the
conclusion that expressing BOP1 enhances mTORC1
signalling. When eIF4E was isolated from cell lysates
(by affinity chromatography on m7GTP-Sepharose
beads), we observed partial loss of 4E-BP1 associated
with eIF4E concomitant with its increased
phosphorylation (Figure 1G). Conversely, as expected,
the association of eIF4E with eIF4G increased,
indicating enhanced formation of cap-binding initiation
complexes.
S6K1 promotes translation elongation by
phosphorylating and inactivating eEF2 kinase (eEF2K),
which phosphorylates and inhibits eEF2 (22). Consistent
with this, expression of BOP1 led to dephosphorylation
of eEF2 (Figure 1H). Expressing BOP1 also led to a
decrease in the expression of eEF2K (Figure 1H).
However, the dephosphorylation of eEF2 preceded the
fall in eEF2K levels, suggesting that the early stages of
this response may be due to inactivation of eEF2K, a
point which is explored in detail below. The
dephosphorylation of eEF2 and the disinhibition of
eIF4E seen in Figure 1G show that BOP1 expression
promotes both the initiation and elongation stages of
mRNA translation. This amounts to an increase in the
efficiency of the translational machinery in the face of in-
sufficient ribosome production.
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Other ways of interfering with rRNA production also
lead to phosphorylation of S6K1 and the
dephosphorylation of eEF2
To assess whether the effect of BOP1 was due specifically
to this truncated protein or interference with rRNA produc-
tion, we examined the effects of other treatments designed to
interfere with this complex. Knock-down of WDR12 or Pes1
interferes with rRNA processing (27,34). Knocking down
BOP1, WDR12 or, to a lesser extent, PES1 also increased
the phosphorylation of HA-S6K1 (Figure 2A and B) or
endogenous S6K1 (Figure 2C and Supplementary Figure
S3A–C) at T389. In contrast, knocking down WDR12 or
BOP1 did not affect the phosphorylation of PKB at S473
(Figure 2A and B and Supplementary Figure S3A and B),
indicating it does not influence mTORC2 function.
The phosphorylation of HA-S6K1 induced by knocking
down BOP1 or WDR12 required the presence of both
amino acids and insulin (Figure 2A and B). Two
different siRNAs directed at BOP1 had similar effects
(Supplementary Figure S3C). Thus, any of these ways of
impairing PeBoW function leads to enhanced phosphoryl-
ation of S6K1 and dephosphorylation of eEF2, consistent
with enhanced mTORC1 signalling.
It was important to examine whether other ways of
disrupting ribosome biogenesis induce a similar effect;
we therefore tested the effect of actinomycin D at low
concentrations, which selectively inhibit Pol I [rather than
the higher concentrations used earlier (35), which inhibit
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Figure 2. Interference with the PeBoW complex regulates effectors of mTORC1. (A and B) HEK293 cells were transfected with 0.5 mg of HA-S6K1
DNA; 24 h later, cells were transfected with scrambled siRNA or siRNA against BOP1 (20 nM) as indicated. After 48 h, cells were starved overnight
of serum and in some cases, subsequently starved of amino acids (1 h). Some cells were then stimulated with insulin (100 nM; 30min). Cell lysates
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other RNA polymerases]. This also elicited the gradual
phosphorylation of S6K1 (Figure 2D). Thus, distinct
ways of interfering with rRNA production have a
common outcome, i.e. activation of mTORC1 signalling
and increased S6K1 phosphorylation.
Induction of BOP1" interferes with polyribosome
formation and protein synthesis
Although expression of BOP1 enhances mTORC1
signalling, it also interferes with ribosome biogenesis. In
cells overexpressing BOP1, levels of the 60S proteins
RPL5, RPL11 and RPL28 declined (Figure 3A and
Supplementary Figure S3D), perhaps owing to their
rapid degradation (36) because they cannot be
incorporated into ribosomal particles owing to insufficient
mature 28S rRNA, although expressing BOP1 only
caused a slight decrease in the 40S component RPS19.
Levels of 40S subunit proteins also declined, but to a
lesser extent (Supplementary Figure S3D). Given the
decrease in the levels of components of the 60S subunit,
we anticipated that overall protein synthesis might de-
crease. Consistent with this idea, induction of BOP1
for 15 h decreased the rate of protein synthesis by
75% (Figure 3B).
To further assess the impact of interfering with the
PeBoW complex on the translational machinery, we
induced BOP1 for various times, and then fractionated
the resulting cell lysates on sucrose density gradients. A
marked decrease in 60S subunits (Figure 3C) was already
evident by 3 h, reflecting their impaired production. There
was little effect on the profile of polysomal particles at 3 or
6 h, apart from the appearance of a ‘shoulder’ on the
faster-sedimenting side of especially the first peak in the
polysome region, which likely reflects accumulation of
‘half-mers’, i.e. polysomes containing one (or more)
complete ribosomes plus a 40S subunit, reflecting the
shortage of 60S subunits. At later times, there was a
further loss of polyribosomes and a striking further
increase in ‘half-mers’ (Figure 3C and Supplementary
Figure S3F).
The mRNAs for RPs contain 50-terminal tracts of
oligopyrimidines (50-TOPs), which confer positive regula-
tion by mTORC1 (37,38). We analysed the polysomal as-
sociation of two 50-TOP mRNAs for components of the
translational machinery, eEF1A and RPL11 and the
b-actin mRNA (a translationally efficient, non-50-TOP
mRNA) (Figure 3C). All three were associated with poly-
somes under control conditions (RPL11 with smaller ones
than the other two, reflecting its short coding region) and
remained associated with the polysomal region of the
profile after induction of BOP1, rather than appearing
in the non-translated fraction at the top of the gradient,
despite the overall decrease in polysome levels. This shows
that the recruitment of ribosomes on to 50-TOP mRNAs
remains active under these conditions (Figure 3C). This is
consistent with the enhanced activity of mTORC1
signalling observed in cells expressing BOP1 and the
well-known role of mTORC1 signalling in driving
50-TOP mRNA translation. In line with the idea that
mTORC1 signalling maintains the recruitment of
ribosomes on to these 50-TOP mRNAs in cells expressing
BOP1, PP242 caused them to shift markedly out of
polysomes (Figure 3D). The continued polysomal associ-
ation of the 50-TOP mRNAs in BOP1-expressing cells
contrasts with the behaviour of other mRNAs, such as
those for the pro-survival proteins Mcl1 and Bcl2, which
shifted towards smaller polysomes (or non-polysomal
fractions) under this condition (Figure 3D). Thus, the
continued association of 50-TOP mRNAs with ribosomes
is not a general feature of all mRNAs under this
condition.
Even after long-term (72 and 96 h) BOP1 induction,
the 50-TOP mRNAs for eEF1A, RPS19 and RPL11
remained associated with multiple ribosomes to a greater
extent than in control cells, whereas the non-TOP mRNAs
for HnRNP A3 and b-actin tended to shift slightly away
from this region of the profile (Supplementary Figure S4A
and B). Serum starvation normally causes a shift of
50-TOP mRNAs out of polysomes (39). In cells expressing
BOP1, in contrast, the 50-TOP mRNA for eEF1A
remained associated with polysomes (more than in
control cells) after serum-starved cells (Supplementary
Figures S4B and S5A shows that BOP1 also induces
eEF2 dephosphorylation in serum-starved cells). The
increased polysomal association of 50-TOP mRNAs in
cells expressing BOP1 likely reflects the activation of
mTORC1 signalling in them. This effect may again
represent a cellular attempt to compensate for impaired
ribosome biogenesis, but one that is ultimately ineffective
given the deficiency in mature rRNA molecules and there-
fore in active ribosomes.
Interestingly, analysis of the ribosomal pellet from the
cytoplasm of cells expressing GST-BOP1 or myc-BOP1
indicated that BOP1/BOP1 interacts with ribosomes
(Supplementary Figure S3D and E). Fractionation of
lysates from cells expressing BOP1 on sucrose density
gradients revealed that some BOP1 is associated with
polysomal region (Supplementary Figure S3F).
Addressing the mechanism by which mTORC1 is
activated after disruption of rRNA production
It is well-established that mTORC1 signalling can be
activated by PKB via phosphorylation of TSC1/2 (15).
However, expression of BOP1 or knock-down of
WDR12 did not affect the phosphorylation of PKB
(Figures 1E and 2A and B). Expressing BOP1 did
cause a modest increase in the phosphorylation of ERK
(Figure 2E), signalling through which can activate
mTORC1 [see, e.g. (40)]. Nonetheless, complete
blockade of this pathway using AZD6244 did not
prevent the BOP1-induced phosphorylation of S6
(Figure 2E), although it did affect the phosphorylation
of eEF2, indicating an input from this pathway, perhaps
via p90RSK (24). Under some conditions, mTORC1 can be
regulated by the ‘stress-activated’ p38 MAP kinase
pathway (41,42). Induction of BOP1 did not increase
the phosphorylation of p38 MAPK (Supplementary
Figure S3G), although it was enhanced by treating cells
with sodium arsenite, used as a ‘positive control’ (data not
shown).
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Activation of mTORC1 requires its amino acid-induced
association with lysosomes (43). Importantly, induction of
BOP1 increased the localization of mTOR to lysosomes,
as assessed using the lysosomal marker LAMP2 (merged
image, Figure 4A), especially in the absence of amino
acids. Amino acid starvation caused a marked transloca-
tion of mTOR from lysosomes to the cytoplasm in control
cells (Figure 4A), confirming these cells respond to amino
acid starvation as expected. Our data suggest that BOP1
expression promotes mTORC1 signalling by inducing the
localization of mTOR to a cellular locale where it is
known to be activated. It has been shown previously
that Rag proteins are critical for the lysosomal localiza-
tion of mTORC1 and its activation (43,44). To study the
role of the Rags in the control of mTORC1 signalling in
response to expressing BOP1, we overexpressed either
constitutively active Rags (RagB[Q99L]/RagC[S75L]
or inactive Rag mutants (RagB[T54L]/RagC[Q120L])
(43,44); their expression was verified by western blot
(Supplementary Figure S6A). We then used
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Figure 3. 50-TOP mRNAs are translationally active in cells expressing BOP1. (A) T-REx cells were treated for 15 h with 1 mg/ml doxycycline and
samples subjected to western blot. (B) The rate of protein synthesis was then analysed by incorporation of [35S]methionine. Data are derived
from three independent experiments. Significance was determined by Student’s t-test. (C) The T-REx cells were induced for the indicated times
with 1 mg/ml doxycycline and lysates were fractionated on sucrose-density gradients. Positions of the 40S, 60S and 80S ribosomal particles and
polysomes are shown; absorbance values at 254 nm are in arbitrary units and are on the same scale for each panel. RNA was extracted from each
fraction and subjected to northern blot using probes specific for eEF1A, b-actin, RPL11 and Mcl1 mRNAs. (D) The T-REx cells were treated with
1 mg/ml doxycycline for 48 h and with 1 mM PP242 for 15 h. The lysate was fractionated on sucrose-density gradients. RNA was extracted from each
fraction and subjected to northern blot using probes specific for eEF1A, b-actin, RPL11, Bcl2 and Mcl1 mRNAs.
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immunofluorescence to study the localization of mTOR in
the absence or presence of the expression of BOP1 and
with/without amino acids. Co-localization was assessed
using Costes’ method [see (45)]. This confirmed that
BOP1 enhanced the association of mTOR with lyso-
somes (Supplementary Figure S6B). As expected, the ex-
pression of the active Rag mutants increased the
lysosomal levels of mTOR, even in the absence of amino
acids, and BOP1 caused a further increase
(Supplementary Figure S6C). The inactive Rag mutants
decreased lysosomal mTOR, even when amino acids
were present (Supplementary Figure S6D), but did not
prevent the increase caused by BOP1, although they
did appear to blunt this effect somewhat. This implies
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Figure 4. Expression of BOP1 affects the localization of mTOR but not intracellular amino acid levels. (A) Cells inducibly expressing myc-BOP1
were cultured in complete medium with/without doxycycline for 48 h, and then without serum in presence (+AA) or absence (AA) of amino acids
for 1 h. Analysis by immunofluorescence staining used mTOR (green) and LAMP2 (red) antibodies. Yellow dots represent co-localization. Scale bar,
10 mm. (B) Cells inducibly expressing myc-BOP1 were cultured in complete medium with/without doxycycline for 48 h. Cells were then lysed in
ice-cold H2O, deproteinized and dried. Amino acid levels were determined by high performance liquid chromatography.
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that the effect of BOP1 on the localization of mTOR is
not dependent on active Rags, and suggests additional
mechanisms are involved here.
In addition, expressing BOP1 did not significantly
affect intracellular levels of any amino acids tested,
including the branched-chain amino acids, which exert
the greatest effects on mTORC1 (Figure 4B) (46),
perhaps because the cells are in medium replete with
amino acids, so that intracellular levels are already
relatively high. Inhibiting protein synthesis with
cycloheximide also did not further enhance amino acid
levels, in contrast to the situation in amino acid-starved
cells (47). Furthermore, because the activation of
mTORC1 caused by expressing BOP1 is still stimulated
by amino acids (Supplementary Figure S1B), localization
to lysosomes is insufficient to activate mTORC1 in this
setting and an additional input from amino acids
appears to be needed.
Expression of BOP1" promotes the inactivation of eEF2K
The decreased phosphorylation of eEF2 caused by
interfering with rRNA processing likely reflects the fact
that mTORC1 signalling is activated under these condi-
tions and that this pathway negatively regulates eEF2K,
e.g. via S6K1 (24,48) combined with the decrease in
eEF2K protein (Figure 1H). To test whether eEF2K is
an inherently unstable protein and/or whether its stability
is decreased by expressing BOP1, we examined endogen-
ous eEF2K levels in control or BOP1-expressing cells
during treatment for various times with cycloheximide.
At all times tested, eEF2K levels were lower in cells ex-
pressing BOP1 than controls, but did not decline over
120min under either condition (Supplementary Figure
S5B), indicating eEF2K is not intrinsically unstable or
destabilized following BOP1 induction.
The proteasome inhibitor MG132 prevented the
BOP1-induced decrease in total eEF2K (Figure 5A),
and also enhanced eEF2K levels in control cells, consist-
ent with an earlier report that eEF2K levels can be
regulated via the proteasome (49). Although MG132 did
blunt the decrease in eEF2 phosphorylation caused by
inducing BOP1, it did not prevent it, confirming that
additional regulatory events, which probably repress
eEF2K activity, are also involved (Figure 5A). Analysis
of the levels of the eEF2K mRNA revealed that BOP1
expression led to a fall in this mRNA, which was reversed
by PP242 after overnight treatment (Figure 5B), indicating
that the mTOR signalling can negatively control eEF2K
mRNA expression, at least under these conditions.
However, PP242 only slightly reversed the decrease in
eEF2K protein levels at longer times (Figure 5C). This
may indicate that additional mechanisms regulate the
level of eEF2K itself or simply the ability of PP242 to
inhibit protein synthesis (impairing the recovery in
eEF2K protein levels).
We next used specific signalling inhibitors to further
explore the mechanisms underlying the control of S6K1
and eEF2K in cells expressing the BOP1 truncation
mutant. To test the role of S6K in the control of
eEF2K/eEF2 in this setting, we used the S6K inhibitor
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Figure 5. Regulation of eEF2K in cells expressing BOP1. (A) T-REx cells were treated for 15 h with 1 mg/ml doxycycline and then for 1 h with
20 mg of MG132. Cell lysates were subjected to western blot. (B) T-REx cells were treated for 15 h with 1 mg/ml doxycycline and treated with PP242
(1 mM, 15 h). Total RNA was extracted and subjected to RT-qPCR analysis for eEF2K and b-actin mRNAs. The significance was determined by
t-test. (C) T-REx cells expressing BOP1 were cultured in complete medium with/without doxycycline. After 33 h, in some cases, cells were treated
with 1 mM PP242 or 100 nM rapamycin for 15 h. Cells were lysed and 20 mg of lysate proteins were used for western blot analysis. (D) T-REx cells
inducibly expressing BOP1 were cultured in complete medium with/without doxycycline. After 36 h, in some cases, cells were treated overnight with
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eEF2K using eEF2 and [g-32P]ATP as substrates.
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PF-4708671 (50). This compound blocked the BOP1-
induced phosphorylation of RPS6 and also promoted
the phosphorylation of eEF2 (Figure 2E), confirming
that S6K1 provides a link between mTORC1 and
eEF2K here. However, it did not prevent the partial loss
of eEF2K protein (Figure 2E) and only partially reversed
the decrease in eEF2K activity seen in cells expressing
BOP1 (Figure 5D). [As reported earlier (50), this
compound tends to enhance the phosphorylation of
S6K1; Figure 2E]. To assess whether other effects down-
stream of mTOR might be involved in regulating eEF2K
here, we tested the effects of rapamycin and the mTOR
kinase inhibitor PP242 (11). At short treatment times
(1 h), rapamycin reversed the BOP1-induced decrease
in p-eEF2, but did not affect the eEF2K protein level
(Figure 2E). Even at longer times (16 h), only PP242,
and not rapamycin, caused a small increase in the levels
of eEF2K protein and a larger rise in EEF2K mRNA
(Figure 5B and C). Given that BOP1 does not alter
the phosphorylation of PKB at S473 (e.g. Figure 1E),
this may involve rapamycin-insensitive functions of
mTORC1 (12,13) rather than mTORC2.
Induction of BOP1 caused a profound inhibition of
eEF2K activity (measured in vitro), which was much more
marked than the decrease in eEF2K protein levels
(Figure 5D). The S6K inhibitor PF-4708671 partially
reversed this effect, whereas rapamycin overcame it com-
pletely (Figure 5D), likely reflecting additional links
between mTORC1 and eEF2K activity (24,51).
DISCUSSION
Ribosome biogenesis and protein synthesis are intimately
linked, as the former provides the ribosomes required to
catalyse the synthesis of new polypeptides and the latter
provides the RPs that are essential for ribosome biogenesis.
This study demonstrates that defects in the former process
impact on signalling events that control mRNA transla-
tion. We show that impairing the transcription or process-
ing of rRNA, by using low doses of actinomycin D or
interfering with the PeBoW complex (by expressing
BOP1 or knocking down its components), respectively,
leads to the activation of S6K and the dephosphorylation
of eEF2, a protein whose activity is indirectly regulated by
S6K (22). Interference with rRNA production also led to
decreased expression of eEF2K at both the mRNA and
protein levels, providing an additional mechanism by
which elongation can be stimulated. We also observe phos-
phorylation (i.e. inactivation) of the translational inhibitor
protein, 4E-BP1, and concomitant disinhibition of eIF4E,
a key component of the translation initiation machinery.
These data show that human cells respond to these defects
in rRNA production by activating a signalling pathway,
mTORC1, which positively regulates both the initiation
and elongation stages of mRNA translation. Because
mTORC1 also positively regulates ribosome biogenesis at
the levels of rRNA transcription and the translation of the
50-TOP mRNAs that encode RPs, activation of mTORC1
may represent a concerted attempt by the cell to ‘rescue’
both mRNA translation and ribosome production in
situations where the latter is defective. In both the
settings we have studied, the attempt is actually fruitless
because of the ongoing inhibition of rRNA synthesis
(actinomycin D treatment) or impairment of the PeBoW
complex, which causes a deficiency of 60S subunits.
However, in physiological settings, this mechanism may
well serve to help balance the production of rRNA and
RPs, and to help cells compensate for deficits in ribosome
biogenesis (see the scheme in Supplementary Figure S7).
Although previous work in yeast (52) has shown that
deleting substrates for TORC1 that are involved in
ribosome biogenesis (Sch9, a protein kinase and Sfp1)
caused activation of TORC1 signalling, the underlying
mechanism remained unclear. Our data provide the first
evidence that impaired ribosome biogenesis elicits an analo-
gous response in mammalian cells. It is important to em-
phasize that here we observe activation of mTORC1
signalling (i) on interfering specifically with rRNA produc-
tion in distinct ways and (ii) without deleting substrates for
mTORC1, which had already been shown to elicit increased
phosphorylation of other mTORC1 substrates (e.g. S6K is
hyperphosphorylated in 4E-BP1/2 knockout cells (53),
perhaps due to relaxed competition between them for
binding to mTORC1. Here, we observe the activation of
mTORC1 signalling independently of deleting substrates of
mTORC1, under differing conditions, which have the
common consequence of disrupting rRNA synthesis.
Defects in rRNA synthesis or processing cause transloca-
tion of mTOR to lysosomes, where this complex can be
activated by Rheb, suggesting a possible mechanism by
which mTORC1 is activated under these conditions;
however, despite our attempts to investigate them, the
mechanisms underlying this and the ensuing activation of
mTORC1 remain to be fully elucidated.
A further, potentially important, finding from our study
is that although BOP1 can promote the association of
mTOR with lysosomes, as can amino acids (43,44),
the activation of mTORC1 signalling by BOP1 still
requires the addition of amino acids. This implies that,
at least in this situation, localization of mTOR on lyso-
somes is insufficient to stimulate mTORC1 signalling.
Other recent data (54) also suggest that the control of
mTORC1 by amino acids is more complicated than
previously thought.
Our findings also reveal that eEF2K is regulated at the
level of its mRNA by signalling downstream of mTOR, in
addition to the well-established control of its enzymatic
activity by mTORC1 (23).
BOP1 associates with nuclear (pre-)ribosomes (27); our
data show it is also associated with cytoplasmic ribo-
somes, in common with some other proteins involved in
ribosome biogenesis [e.g. Rli1p/ABCE1 (55–57) and eIF6
(58)]. Interestingly, increased dosage of the BOP1 gene is
associated with colorectal cancer and enhanced levels of
BOP1 mRNA (59).
Importantly, our data show that the effects of
interfering with the production (transcription or process-
ing) of rRNA contrast with those of decreasing the avail-
ability of RPs, by RNA interference or due to Diamond
Blackfan Anaemia, an inherited disorder caused by muta-
tions in RP genes (60). These conditions cause defective
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ribosome synthesis but lead to impairment, rather than
activation, of mTORC1 signalling [(61,62) and our unpub-
lished findings]. Consistent with this, treatment of
Diamond Blackfan Anaemia patients with leucine, which
promotes mTORC1 signalling (46), can ameliorate their
symptoms [see also (63)].
Overall, the present data further extend the repertoire of
regulatory loops that impinge on ribosome biogenesis to
reveal a new one that regulates the translational machin-
ery and helps cells maximize the productivity of the
existing ribosomes by activating initiation and elongation
under conditions of ‘ribosome stress’.
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